BioVie Inc. BIVI
1.61
0.00
0.00%
as of 25 Sep
- Market cap
- $13.8M
- P/E
- 0.0×
Follow BIVI
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
3.59 | 9.97 | 7.25 | 15.83 |
+8 more quarters Free account |
Net Debt/EBITDA |
1.57 | 2.46 | 3.31 | 4.78 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.73 | 1.41 | 0.73 | 0.59 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.57) | (0.99) | (0.56) | (0.58) | |
Cash per Share |
1.24 | 1.74 | 2.59 | 4.79 | |
Shareholders Equity per Share |
1.42 | 2.07 | 2.43 | 4.78 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.42 | 2.07 | 2.43 | 4.78 | |
Free Cash Flow |
(4.12) | (7.44) | (4.44) | (3.02) | |
Working Capital |
9.85 | 15.19 | 18.79 | 24.39 | |
Net Current Asset Value |
9.66 | 14.97 | 18.55 | 24.13 | |
| Other line items | |||||
Quick Ratio |
2.93 | 9.02 | 6.90 | 15.30 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.57) | (0.99) | (0.56) | (0.58) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Receivables |
2.13 | — | — | — | |
Average Payables |
2.95 | 2.04 | 2.15 | 2.51 | |
Average Assets |
17.91 | 21.09 | 24.10 | 24.03 | |
Average Common Equity |
14.64 | 18.71 | 21.59 | 19.49 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates